<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03453645</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/17/0066</org_study_id>
    <secondary_id>2017-A00582-51</secondary_id>
    <nct_id>NCT03453645</nct_id>
  </id_info>
  <brief_title>Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation</brief_title>
  <official_title>Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sudden cardiac death is a frequent cause of cardiovascular mortality. Numerous rhythmic risk
      assessment criterion have been described targeting the substratum, the cardiac nervous tone
      or the trigger of arrhythmias. Development of ventricular tachycardia ablation in the past
      few years show interesting results preventing the recurrence of ventricular arrhythmias.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sudden cardiac death is a frequent cause of cardiovascular mortality. Numerous rhythmic risk
      assessment criterion have been described targeting the substratum, the cardiac nervous tone
      or the trigger of arrhythmias. Development of ventricular tachycardia ablation in the past
      few years show interesting results preventing the recurrence of ventricular arrhythmias.

      Rhythmic risk assessment criterions have never been studied in relation with ventricular
      tachycardia ablation. The purpose of this study is to explore the modifications of these
      criterions after ventricular tachycardia ablation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 9, 2017</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>measure assessing change before and after Ventricular Tachycardia Ablation of the non-invasive parameters analysis of the rhythmic risk before and after Ventricular Tachycardia Ablation</measure>
    <time_frame>10 minutes and 60 minutes after the Ventricular Tachycardia Ablation</time_frame>
    <description>non invasive parameters analysis of the rhythmic risk will be evaluated by the evaluation of the T wave alternans</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessing the correlations of the modifications of the risk criterion after ablation with the recurrences of arrhythmias at one year follow-up</measure>
    <time_frame>3 months, 6 months and 12 months after the Ventricular Tachycardia Ablation</time_frame>
    <description>the recurrences of arrhythmias will be evaluated . There will be assessed by the informations reveled by the Implantable automatic defibrillator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study of the correlation between the modifications of non-invasive parameters analysis of the rhythmic risk and the success of the ablation procedure</measure>
    <time_frame>3 months, 6 months and 12 months after the Ventricular Tachycardia Ablation</time_frame>
    <description>Success of the ablation procedure is defined by the absence of inducible Ventricular Tachycardia at the end of the procedure.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Ventricular Tachycardia</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ventricular tachycardia ablation</intervention_name>
    <description>The usual organization of hospitalization of the patients addressed for ventricular tachycardia ablation and his follow-up are not modified by the protocol. .</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        people wich an Ventricular Tachycardia Ablation necessary and programed
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing ventricular tachycardia,

          -  patients with ischemic cardiomyopathy according to European Society of Cardiology
             Guidelines,

          -  patients with implanted cardiac defibrillator.

        Exclusion Criteria:

          -  Contra-indication to stress test,

          -  permanent atrial fibrillation,

          -  permanent ventricular pacing,

          -  left bundle block.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe MAURY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philippe MAURY, MD</last_name>
    <phone>05 61 32 31 00</phone>
    <email>maury.p@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isabelle OLIVIER, PhD</last_name>
    <phone>05 61 77 70 51</phone>
    <phone_ext>+33</phone_ext>
    <email>olivier.i@chu-toulouse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe MAURY, MD</last_name>
      <phone>05 61 32 31 00</phone>
      <email>maury.p@chu-toulouse.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 27, 2017</study_first_submitted>
  <study_first_submitted_qc>February 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2018</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ablation</keyword>
  <keyword>sudden death</keyword>
  <keyword>signal averaged ECG</keyword>
  <keyword>T wave alternans</keyword>
  <keyword>heart rate variability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

